I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Immunochemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Immunochemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Immunochemistry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Hematology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Hematology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Hematology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Clinical
Chemistry by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Clinical Chemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Clinical Chemistry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Molecular
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Molecular Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Molecular Diagnostics
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Oher Applications
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 17: World Historic Review for Oher Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Oher Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 20: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Clinical
Laboratories by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Clinical Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Clinical Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 28: USA Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 29: USA Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 30: USA 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 31: USA Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 32: USA Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 33: USA 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

CANADA
Table 34: Canada Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 35: Canada Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 36: Canada 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 37: Canada Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 38: Canada Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 39: Canada 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

JAPAN
Table 40: Japan Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: Japan Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 42: Japan 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 43: Japan Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: Japan Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 45: Japan 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

CHINA
Table 46: China Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 47: China Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 48: China 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 49: China Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 50: China Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 51: China 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

EUROPE
Table 52: Europe Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 53: Europe Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 54: Europe 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Geographic Region - Percentage
Breakdown of Value Sales for France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets for Years 2012, 2020 & 2027

Table 55: Europe Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 56: Europe Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 57: Europe 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 59: Europe Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 60: Europe 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

FRANCE
Table 61: France Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 62: France Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 63: France 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 64: France Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: France Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 66: France 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

GERMANY
Table 67: Germany Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Germany Historic Review for In Vitro Diagnostics
(IVD) Quality Control by Application - Immunochemistry,
Hematology, Clinical Chemistry, Molecular Diagnostics and Oher
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 69: Germany 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 70: Germany Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 71: Germany Historic Review for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Hospitals, Clinical
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 72: Germany 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

ITALY
Table 73: Italy Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 74: Italy Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 75: Italy 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 76: Italy Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: Italy Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 78: Italy 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 79: UK Current & Future Analysis for In Vitro Diagnostics
(IVD) Quality Control by Application - Immunochemistry,
Hematology, Clinical Chemistry, Molecular Diagnostics and Oher
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 80: UK Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 81: UK 15-Year Perspective for In Vitro Diagnostics (IVD)
Quality Control by Application - Percentage Breakdown of Value
Sales for Immunochemistry, Hematology, Clinical Chemistry,
Molecular Diagnostics and Oher Applications for the Years 2012,
2020 & 2027

Table 82: UK Current & Future Analysis for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Hospitals, Clinical
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 83: UK Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 84: UK 15-Year Perspective for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Percentage Breakdown of Value
Sales for Hospitals, Clinical Laboratories and Other End-Uses
for the Years 2012, 2020 & 2027

SPAIN
Table 85: Spain Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 86: Spain Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 87: Spain 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 88: Spain Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 89: Spain Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 90: Spain 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

RUSSIA
Table 91: Russia Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Russia Historic Review for In Vitro Diagnostics (IVD)
Quality Control by Application - Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 93: Russia 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by Application - Percentage Breakdown of
Value Sales for Immunochemistry, Hematology, Clinical
Chemistry, Molecular Diagnostics and Oher Applications for the
Years 2012, 2020 & 2027

Table 94: Russia Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 95: Russia Historic Review for In Vitro Diagnostics (IVD)
Quality Control by End-Use - Hospitals, Clinical Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 96: Russia 15-Year Perspective for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Percentage Breakdown of
Value Sales for Hospitals, Clinical Laboratories and Other
End-Uses for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 97: Rest of Europe Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 98: Rest of Europe Historic Review for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by Application - Percentage
Breakdown of Value Sales for Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
for the Years 2012, 2020 & 2027

Table 100: Rest of Europe Current & Future Analysis for In
Vitro Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 101: Rest of Europe Historic Review for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 102: Rest of Europe 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Percentage
Breakdown of Value Sales for Hospitals, Clinical Laboratories
and Other End-Uses for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2020 through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for In Vitro
Diagnostics (IVD) Quality Control by Geographic Region -
Australia, India, South Korea and Rest of Asia-Pacific Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by Geographic Region -
Percentage Breakdown of Value Sales for Australia, India, South
Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 &
2027

Table 106: Asia-Pacific Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 107: Asia-Pacific Historic Review for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 108: Asia-Pacific 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by Application - Percentage
Breakdown of Value Sales for Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
for the Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 110: Asia-Pacific Historic Review for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 111: Asia-Pacific 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Percentage
Breakdown of Value Sales for Hospitals, Clinical Laboratories
and Other End-Uses for the Years 2012, 2020 & 2027

AUSTRALIA
Table 112: Australia Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 113: Australia Historic Review for In Vitro Diagnostics
(IVD) Quality Control by Application - Immunochemistry,
Hematology, Clinical Chemistry, Molecular Diagnostics and Oher
Applications Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 114: Australia 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by Application - Percentage
Breakdown of Value Sales for Immunochemistry, Hematology,
Clinical Chemistry, Molecular Diagnostics and Oher Applications
for the Years 2012, 2020 & 2027

Table 115: Australia Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Hospitals,
Clinical Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: Australia Historic Review for In Vitro Diagnostics
(IVD) Quality Control by End-Use - Hospitals, Clinical
Laboratories and Other End-Uses Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 117: Australia 15-Year Perspective for In Vitro
Diagnostics (IVD) Quality Control by End-Use - Percentage
Breakdown of Value Sales for Hospitals, Clinical Laboratories
and Other End-Uses for the Years 2012, 2020 & 2027

INDIA
Table 118: India Current & Future Analysis for In Vitro
Diagnostics (IVD) Quality Control by Application -
Immunochemistry, Hematology, Clinical Chemistry, Molecular
Diagnostics and Oher Applications - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents